1-Ethyl-5-(5-furan-2-yl-penta-2,4-dienylidene)-2-thioxodihydro-pyrimidine-4,6-dione

ID: ALA4177462

PubChem CID: 145972953

Max Phase: Preclinical

Molecular Formula: C15H14N2O3S

Molecular Weight: 302.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)/C(=C\C=C\C=C\c2ccco2)C(=O)NC1=S

Standard InChI:  InChI=1S/C15H14N2O3S/c1-2-17-14(19)12(13(18)16-15(17)21)9-5-3-4-7-11-8-6-10-20-11/h3-10H,2H2,1H3,(H,16,18,21)/b5-3+,7-4+,12-9-

Standard InChI Key:  RWOPIXPNFHZSRA-LYDVKKHVSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   10.7978  -11.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5122  -10.7501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2267  -11.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2267  -11.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5122  -12.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7978  -11.9876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9412  -10.7501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5122  -13.2251    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0833  -10.7501    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.9412  -12.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9412  -13.2251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6557  -13.6376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6557  -14.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3701  -14.8751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7027  -16.1850    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3701  -15.7001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0376  -16.1850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7826  -16.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9576  -16.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0833  -12.4001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3688  -11.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  6  1  0
  3  7  2  0
  5  8  2  0
  1  9  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 15 19  1  0
 14 16  1  0
  4 10  2  0
 20 21  1  0
  6 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4177462

    ---

Associated Targets(Human)

CHL-1 (186 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-903 (393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 302.36Molecular Weight (Monoisotopic): 302.0725AlogP: 2.04#Rotatable Bonds: 4
Polar Surface Area: 62.55Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.70CX Basic pKa: CX LogP: 2.37CX LogD: 2.19
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.40Np Likeness Score: -1.05

References

1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK..  (2018)  Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells.,  143  [PMID:29133035] [10.1016/j.ejmech.2017.11.006]

Source